The hydrocortisone protection of glycocalyx on the intestinal capillary endothelium during severe acute pancreatitis

Shock

Volumn 43, Issue 5, 2015, Pages 512-517

  Gao, Shun Liang ^a   Zhang, Yun ^a   Zhang, Shao Yang ^a   Liang, Zhong Yan ^a   Yu, Wen Qiao ^a   Liang, Ting Bo ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

capillary leak syndrome; glycocalyx; hydrocortisone; intestinal mucosal barrier; Severe acute pancreatitis

Indexed keywords

HEPARAN SULFATE; HYDROCORTISONE; SYNDECAN 1; TAUROCHOLIC ACID; TUMOR NECROSIS FACTOR ALPHA; SDC1 PROTEIN, RAT;

ACUTE PANCREATITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CAPILLARY ENDOTHELIUM; CELL PROTECTION; CONTROLLED STUDY; ELECTRON MICROSCOPY; GLYCOCALYX; INTESTINAL MUCOSAL INJURY; INTESTINE INJURY; INTESTINE MUCOSA; INTESTINE PERFUSION; LASER DOPPLER FLOWMETRY; MALE; MICROCIRCULATION; NONHUMAN; PANCREAS DUCT; RAT; SUPERIOR MESENTERIC VEIN; VASCULAR ENDOTHELIUM; ANIMAL; CELL ADHESION; CHEMISTRY; DISEASE MODEL; DRUG EFFECTS; INTESTINE; MESENTERIC VEIN; METABOLISM; MICROBIOLOGY; PANCREATITIS; PERFUSION; PERMEABILITY; SEPSIS; SPRAGUE DAWLEY RAT; TIME;

ANIMALS; CELL ADHESION; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; GLYCOCALYX; HEPARITIN SULFATE; HYDROCORTISONE; INTESTINES; MALE; MESENTERIC VEINS; MICROCIRCULATION; PANCREATITIS; PERFUSION; PERMEABILITY; RATS; RATS, SPRAGUE-DAWLEY; SEPSIS; SYNDECAN-1; TAUROCHOLIC ACID; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84928645855     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0000000000000326     Document Type: Article

References (28)

1. Ammori BJ: Role of the gut in the course of severe acute pancreatitis. Pancreas 26(2):122-129, 2003.
2. Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med 348(2):138-150, 2003.
3. Cabrales P, Vazquez BY, Tsai AG, Intaglietta M: Microvascular and capillary perfusion following glycocalyx degradation. J Appl Physiol 102(6): 2251-2259, 2007.
4. Chappell D, Dorfler N, Jacob M, Rehm M, Welsch U, Conzen P, Becker BF: Glycocalyx protection reduces leukocyte adhesion after ischemia/reperfusion. Shock 34(2):133-139, 2010.
5. Marechal X, Favory R, Joulin O, Montaigne D, Hassoun S, Decoster B, Zerimech F, Neviere R: Endothelial glycocalyx damage during endotoxemia coincides with microcirculatory dysfunction and vascular oxidative stress. Shock 29(5):572-576, 2008.
6. Chappell D, Jacob M, Hofmann-Kiefer K, Bruegger D, Rehm M, Conzen P, Welsch U, Becker BF: Hydrocortisone preserves the vascular barrier by protecting the endothelial glycocalyx. Anesthesiology 107(5):776-784, 2007.
7. Yoshida J, Yamamoto K, Mano T, Sakata Y, Nishikawa N, Nishio M, Ohtani T, Miwa T, Hori M, Masuyama T: AT1 receptor blocker added to ACE inhibitor provides benefits at advanced stage of hypertensive diastolic heart failure. Hypertension 43(3):686-691, 2004.
8. Asakura M, Kitakaze M, Takashima S, Liao Y, Ishikura F, Yoshinaka T, Ohmoto H, Node K, Yoshino K, Ishiguro H, et al.: Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy. Nat Med 8(1):35-40, 2002.
9. Singh DB, Stansby G, Bain I, Harrison DK: Intraoperative measurement of colonic oxygenation during bowel resection. Adv Exp Med Biol 645: 261-266, 2009.
10. Vogel J, Sperandio M, Pries AR, Linderkamp O, Gaehtgens P, Kuschinsky W: Influence of the endothelial glycocalyx on cerebral blood flow in mice. J Cereb Blood Flow Metab 20(11):1571-1578, 2000.
11. Rehm M, Zahler S, Lotsch M, Welsch U, Conzen P, Jacob M, Becker BF: Endothelial glycocalyx as an additional barrier determining extravasation of 6% hydroxyethyl starch or 5% albumin solutions in the coronary vascular bed. Anesthesiology 100(5):1211-1223, 2004.
12. Oktar BK, Gulpinar MA, Bozkurt A, Ghandour S, Cetinel S, Moini H, Yegen BC, Bilsel S, Granger DN, Kurtel H: Endothelin receptor blockers reduce I/R-induced intestinal mucosal injury: role of blood flow. Am J Physiol Gastrointest Liver Physiol 282(4):G647-G655, 2002.
13. Schmidt J, Rattner DW, Lewandrowski K, Compton CC, Mandavilli U, Knoefel WT, Warshaw AL: A better model of acute pancreatitis for evaluating therapy. Ann Surg 215(1):44-56, 1992.
14. Barrowman JA, Kvietys PR, Granger DN, McElearney PM, Perry MA: Effects of the constituents of a corticosteroid enema preparation on colonic blood flow and oxygen uptake in the dog. J Pharmacol Exp Ther 226(1): 217-221, 1983.
15. Sha H, Ma Q, Jha RK, Wu Z, Qingyuan Z, Wang Z, Ma Z, Luo X, Liu C: Resveratrol suppresses microcirculatory disturbance in a rat model of severe acute pancreatitis. Cell Biochem Biophys 67(3):1059-1065, 2013.
16. Samonte VA, Goto M, Ravindranath TM, Fazal N, Holloway VM, Goyal A, Gamelli RL, Sayeed MM: Exacerbation of intestinal permeability in rats after a two-hit injury: burn and Enterococcus faecalis infection. Crit Care Med 32(11):2267-2273, 2004.
17. Sir O, Fazal N, Choudhry MA, Goris RJ, Gamelli RL, Sayeed MM: Role of neutrophils in burn-induced microvascular injury in the intestine. Shock 14(2):113-117, 2000.
18. Calvet X, Baigorri F, Duarte M, Joseph D, Saura P, Mas A, Royo C, Artigas A: Effect of sucralfate on gastric intramucosal pH in critically ill patients. Intensive Care Med 23(7):738-742, 1997.
19. Henry CB, Duling BR: Permeation of the luminal capillary glycocalyx is determined by hyaluronan. Am J Physiol 277(2 Pt 2):H508-H514, 1999.
20. Henry CB, Duling BR: TNF-alpha increases entry of macromolecules into luminal endothelial cell glycocalyx. Am J Physiol Heart Circ Physiol 279(6): H2815-H2823, 2000.
21. Chappell D, Hofmann-Kiefer K, Jacob M, Rehm M, Briegel J, Welsch U, Conzen P, Becker BF: TNF-alpha induced shedding of the endothelial glycocalyx is prevented by hydrocortisone and antithrombin. Basic Res Cardiol 104(1):78-89, 2009.
22. Cook DN, Pisetsky DS, Schwartz DA: Toll-like receptors in the pathogenesis of human disease. Nat Immunol 5(10):975-979, 2004.
23. Mukaida N, Zachariae CC, Gusella GL, Matsushima K: Dexamethasone inhibits the induction of monocyte chemotactic-activating factor production by IL-1 or tumor necrosis factor. J Immunol 146(4):1212-1215, 1991.
24. Grunfeld JP, Eloy L: Glucocorticoids modulate vascular reactivity in the rat. Hypertension 10(6):608-618, 1987.
25. Warnecke HB, Schirmeier A, Nussler AK, Platz KP, Stange B, Nussler NC, Radke C, Neuhaus P, Mueller AR: The combined treatment with L-arginine and methylprednisolone improves graft morphology and mucosal barrier function. Transplant Proc 34(3):996-998, 2002.
26. Geisler FH, Coleman WP, Benzel E, Ducker T, Hurlbert RJ: Spinal cord injury. Lancet 360(9348):1883, 2002.
27. Lombardi D, Gaetani P, Marzatico F, Cafe C, Rodriguez y Baena R: Effect of high-dose methylprednisolone on anti-oxidant enzymes after experimental SAH. J Neurol Sci 111(1):13-19, 1992.
28. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS Jr: Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 270(5234):283-286, 1995.